Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
77.50    -0.90 (-1.15%)
Bid:
77.35
Ask:
77.45
Spread: 0.10 (0.129%)
Market Cap: £1.48b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

20 May 2026 07:00

RNS Number : 9800E
Coats Group PLC
20 May 2026
 

20 May 2026

Coats Group plc

AGM Trading Update

Robust performance year-to-date,

full-year expectations unchanged

 

Coats Group plc ('Coats' or the 'Group'), a world-leading Tier 2 supplier of critical components to the apparel and footwear industries, today announces a trading update for the four month period 1 January to 30 April 2026 (the 'period') ahead of its Annual General Meeting to be held later today.

 

Continuing operations

1st January to 30th April 2026 revenue versus same period in 2025

Organic CER

Reported

Apparel

1%

1%

Footwear

(4)%

55%

Group

(1)%

 18%

 

 

All following references are at organic constant exchange rates (CER) unless specified.

 

The Group delivered a robust performance with revenue 1% lower against a solid pre-tariff comparator period.

 

Apparel revenue was up 1%, strongly outperforming the core thread end market, driven by our key differentiators of operational agility, enduring customer relationships and our global manufacturing capabilities. The division continues to win market share across its portfolio including in China domestic and also saw strong growth in automotive thread.

 

In line with our expectations, Footwear revenue was 4% lower on an organic basis, which we estimate to be inline with industry trends, as customer caution persisted and inventory levels remained low. OrthoLite revenue was lower than the same period last year on a proforma basis against a very strong prior year comparator and temporary capacity challenges in Indonesia, where we are expanding our footprint. Our plans to realise cost synergies are on track and we are increasingly positive on sales synergies. We remain confident in OrthoLite's growth prospects.

 

Group EBIT margin was slightly higher than the same period last year, reflecting the benefits of the 2025 footprint consolidation in Footwear and the positive contribution from OrthoLite.

 

While the ongoing tensions in the Middle East have not had a material impact on trading to date, we are monitoring conditions closely. We have promptly enacted our well-honed operational and commercial playbook ensuring optimal pricing and cost discipline. We will continue to take action as required to mitigate supply chain pressures and raw material and energy cost increases.

 

Outlook

 

The Group's full year outlook remains unchanged with a modest second half profit weighting due to expected inflation cost recovery timing.

 

We expect full year free cash flow generation to remain strong, enabling the Group to continue to reduce leverage into our target range of 1-2x by year-end.

 

 

The Group will release its interim results on Tuesday 28 July 2026. 

 

 

Enquiry details

Investors

Chris Dyett

Coats Group plc

+44 (0) 7974 974 690

Media

Nick Hasell / Victoria Hayns

FTI Consulting

+44 (0)20 3727 1340

About Coats Group plc

 

Coats is a world-leading Tier 2 manufacturer and trusted partner for the apparel and footwear industries. We deliver essential materials, components, and software solutions that help our customers grow, compete and win.

 

With over 250 years of industry expertise, we're shaping the future of the apparel and footwear supply chain through insight-led innovation, impactful sustainability practices, and digital technologies that unlock better product quality, efficiency and performance.

 

Headquartered in the UK, Coats is a FTSE 250 company and a constituent of the FTSE4Good Index. In 2025, we generated $1.5 billion in revenue and employed c.19,000 people worldwide - all united by a spirit of innovation, quality and service. Learn more at www.coats.com or follow us on LinkedIn.

 

LEI: 2138003SPYWGAITNFY17

 

Cautionary statement

 

Certain statements in this trading update are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAKCBNABKDNPD
Date   Source Headline
10th Aug 20224:36 pmRNSAcquisition of Rhenoflex
2nd Aug 20227:00 amRNSHalf-year Report
25th Jul 20222:10 pmRNSHolding(s) in Company
21st Jul 20227:00 amRNSCompletion of acquisition
12th Jul 202212:36 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSAcquisition of Texon
20th Jun 20222:15 pmRNSHolding(s) in Company
27th May 20227:00 amRNSDeal Completion
18th May 20224:09 pmRNSResult of AGM
18th May 20223:31 pmRNSHolding(s) in Company
18th May 20227:00 amRNSTrading Statement
10th May 20227:00 amRNSStrategic exit from Brazil and Argentina
3rd May 20227:00 amRNSBoard Changes
13th Apr 20222:53 pmRNSBlock listing Interim Review
1st Apr 202211:01 amRNSHolding(s) in Company
10th Mar 20223:04 pmRNSAnnual Financial Report
4th Mar 20222:54 pmRNSDirector/PDMR Shareholding
4th Mar 20222:51 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNS2021 Full Year Results
9th Feb 20222:19 pmRNSHolding(s) in Company
7th Feb 20229:59 amRNSHolding(s) in Company
23rd Dec 20211:48 pmRNSHolding(s) in Company
17th Dec 202110:27 amRNSHolding(s) in Company
9th Dec 20211:20 pmRNSDirector/PDMR Shareholding
6th Dec 202112:15 pmRNSDirector/PDMR Shareholding
25th Nov 20213:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSTrading Statement
20th Oct 202112:50 pmRNSHolding(s) in Company
13th Oct 202112:54 pmRNSHolding(s) in Company
7th Oct 20213:31 pmRNSHolding(s) in Company
5th Oct 20212:11 pmRNSBlock listing Interim Review
4th Oct 20211:42 pmRNSHolding(s) in Company
5th Aug 20213:21 pmRNSDirector/PDMR Shareholding
3rd Aug 20217:00 amRNSHalf-year Report
21st Jul 20219:30 amRNSHolding(s) in Company
14th Jul 20217:00 amRNSTrading Statement
25th May 202112:25 pmRNSHolding(s) in Company
19th May 20213:59 pmRNSResult of AGM
19th May 20217:00 amRNSTrading Statement
22nd Apr 202110:22 amRNSHolding(s) in Company
22nd Apr 202110:20 amRNSHolding(s) in Company
19th Apr 20211:52 pmRNSHolding(s) in Company
12th Apr 20212:55 pmRNSBlock listing Interim Review
9th Apr 20219:02 amRNSCompletion of $360m ESG-linked bank refinancing
31st Mar 20212:30 pmRNSTotal Voting Rights
31st Mar 20212:28 pmRNSNotice of AGM
23rd Mar 202112:55 pmRNSHolding(s) in Company
11th Mar 20212:35 pmRNSAnnual Financial Report
5th Mar 20211:18 pmRNSDirector/PDMR Shareholding
5th Mar 20211:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.